glucocorticoids
The therapeutic benefit of immuno-inhibiting agents other than       glucocorticoids in the management of SR asthma deserves further investigation.
The therapeutic benefit of immuno-inhibiting agents other than        @SUBJECT$  in the  @PREDICAT$  of SR  @OBJECT$  deserves further investigation.